✦ LIBER ✦

Risk Stratification of Patients with Newly Diagnosed Multiple Myeloma: Optimizing Treatment Based on Pretreatment Characteristics

✍ Scribed by Chng, Wee J.; Fonseca, Rafael

Book ID: 119935864
Publisher: CIG Media Group, LP.
Year: 2005
Tongue: English
Weight: 141 KB
Volume: 6
Category: Article
ISSN: 1557-9190
DOI: 10.3816/clm.2005.n.047

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The impact of frontline risk-adapted str

The impact of frontline risk-adapted strategy on the overall survival of patients with newly diagnosed multiple myeloma: an analysis of the Singapore multiple myeloma study group

✍ Daryl Tan; Kiat H. Ong; Liang P. Koh; Siew S. Wong; Myat T. Khin; Lai H. Lee; Ye 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB

Consensus guidelines for the optimal man

Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma

✍ A. Palumbo; F. Davies; M. Kropff; J. Bladé; M. Delforge; F. Leal da Costa; R. Ga 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 206 KB

Diffuse pattern of bone marrow involveme

Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: A single center experience on 228 patients

✍ Lia A. Moulopoulos; Meletios A. Dimopoulos; Efstathios Kastritis; Dimitrios Chri 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 918 KB

Prognostic significance of the S-phase f

Prognostic significance of the S-phase fraction of light-chain-restricted cytoplasmic immunoglobulin (cIg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on eastern cooperative oncology group treatment trial E9486

✍ Trendle, M.C.; Leong, T.; Kyle, R.A.; Katzmann, J.A.; Oken, M.M.; Kay, N.E.; Van 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 2 views

The bone marrow plasma cell labeling index (PCLI) as measured by bromodeoxyuridine uptake is a well-established independent prognostic factor for patients with newly diagnosed multiple myeloma, but the test is not easily done in most laboratories. The purpose of this study was to determine if the pr